Tina M. Woo
- Hematology top 2%
- Multiple Myeloma Research and Treatments 7
- Oncology top 10%
- Peptidase Inhibition and Analysis 4
-
- Ubiquitin and proteasome pathways 9
- Protein Degradation and Inhibitors 5
- Histone Deacetylase Inhibitors Research 4
- Cancer therapeutics and mechanisms 1
- Biochemical and Molecular Research 1
-
- HIV/AIDS drug development and treatment 2
- Co-authors
- Christopher J. KirkMarcy K. ValloneFrancesco ParlatiGuy J. LaidigChristopher J. MolineauxKevin D. ShenkTonia J. BuchholzSusan D. Demo
- Cited by
- HematologyOncologyMolecular Biology
- Journals
- Blood (8 papers)Journal of Clinical Oncology (3 papers)Drug Metabolism and Disposition (1 paper)
- Partner nations
- United StatesCanadaNorway
In The Last Decade
Tina M. Woo
13 papers receiving 726 citations
Hit Papers
Peers
Comparison fields: 5 of 56
- Hematology 380
- Oncology 269
- Molecular Biology 620
- Genetics 61
- Cell Biology 41
Countries citing papers authored by Tina M. Woo
This map shows the geographic impact of Tina M. Woo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tina M. Woo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tina M. Woo more than expected).
Fields of papers citing papers by Tina M. Woo
This network shows the impact of papers produced by Tina M. Woo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tina M. Woo. The network helps show where Tina M. Woo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tina M. Woo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 6 | |
| 2 | 2012 | 123 | |
| 3 | 2011 | 19 | |
| 4 | 2011 | 1 | |
| 5 | 2010 | 5 | |
| 6 | 2010 | 19 | |
| 7 | 2009 | 10 | |
| 8 | Antitumor Activity of PR-171, a Novel Irreversible Inhibitor of the Proteasomebreakdown → | 2007 | 542 |
| 9 | 2007 | 1 | |
| 10 | 2006 | 1 | |
| 11 | 2006 | 9 | |
| 12 | 2005 | 2 | |
| 13 | 2005 | 13 |
About Tina M. Woo
Tina M. Woo is a scholar working on Hematology, Oncology, Molecular Biology, Infectious Diseases and Genetics, having authored 13 papers that have together received 751 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (9 papers), Multiple Myeloma Research and Treatments (7 papers), Protein Degradation and Inhibitors (5 papers), Peptidase Inhibition and Analysis (4 papers), Histone Deacetylase Inhibitors Research (4 papers), HIV/AIDS drug development and treatment (2 papers), Cancer therapeutics and mechanisms (1 paper) and Biochemical and Molecular Research (1 paper). The work is most often cited by research in Hematology (380 citations), Oncology (269 citations), Molecular Biology (620 citations), Genetics (61 citations) and Cell Biology (41 citations). Tina M. Woo has collaborated with scholars based in United States, Canada and Norway. Frequent co-authors include Christopher J. Kirk, Marcy K. Vallone, Francesco Parlati, Guy J. Laidig, Christopher J. Molineaux, Kevin D. Shenk, Tonia J. Buchholz, Susan D. Demo, Mark K. Bennett and Mark S. Smyth. Their work appears in journals such as Blood, Journal of Clinical Oncology, Drug Metabolism and Disposition and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.